![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Hyclone New Zealand Tauranga Nz, based in New Zealand, is a pharmaceutical company.
One of their significant offerings is Donor Bovine Calf Serum, (Product codes: SH30417, SH30417.IR, SH30624, SH30627), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-191 - Rev 01
This TSE Type CEP, issued on May 15, 2006, remains in force until September 09, 2020, ensuring its reliability within the pharmaceutical industry.